title: [Can coronary risks be further reduced?].
authors.affiliation: INSERM U541, Hôpital Lariboisière, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Tedgu
authors.forename: G
authors.initials: G
authors.lastname: Dagenais
authors.forename: M
authors.initials: M
authors.lastname: Marre
authors.forename: S-L
authors.initials: SL
authors.lastname: Chierchia
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications* / Q000209:etiology*; D002097:C-Reactive Protein / Q000032:analysis; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D007249:Inflammation; D009203:Myocardial Infarction / Q000209:etiology; D011379:Prognosis; D017257:Ramipril / Q000627:therapeutic use; D012307:Risk Factors; D020521:Stroke / Q000209:etiology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002097:C-Reactive Protein; D017257:Ramipril